Skip to main content
. 2022 Sep 26;46(12):3090–3099. doi: 10.1007/s00268-022-06754-z

Table 1.

Patients and procedure characteristics

Total Series Minor Major p-value
N = 212 (100) N = 188 (89) N = 24 (11)
Technically Minor Technically Major
N = 177 N = 11
Age, years, median (IQR) 56 (18–85) 46 (30–73) 51 (21–80) 0.304
Sex, male 67 (38) 5 (46) 7 (29) 0.602
BMI, Kg/m2, median (IQR) 26.4 (17.9–45.4) 26.5 (21.0–41.2) 26.2 (18.6–36.4) 0.975
ASA
 I 31 (18) 4 (36) 5 (21) 0.525
 II 101 (57) 4 (36) 16 (67)
 III 40 (23) 3 (27) 3 (13)
 IV 4 (2)
Diabetes 32 (18) 2 (18) 5 (21) 0.948
Hypertension 50 (28) 4 (36) 6 (25) 0.786
COPD 10 (6) 0.354
Hepatitis 15 (9) 1 (9) 1 (4) 0.760
Cirrhosis 19 (11) 1 (9) 1 (4) 0.597
Previous abdominal surgery 82 (46) 6 (54) 10 (42) 0.776
Pathology
 Hepatocellular carcinoma 55 (31) 3 (27) 4 (17) 0.006
 Liver metastases 32 (18) 2 (18)
 Benign 80 (45) 4 (36) 18 (75)
 Biliary 10 (6) 2 (18) 2 (8)
Type of resection
 Non anatomical 34 (19)  < 0.001
 Segmentectomy 36 (20) 8 (73)
 Left lateral + other segment 1 (1) 3 (27)
 Left lateral 106 (60)
 Left hemihepatectomy 12 (50)
 Right hemihepatectomy 12 (50)
Approach
 Laparoscopic 147 (83) 10 (91) 17 (71) 0.252
 Robotic 30 (17) 1 (9) 7 (29)
Conversion 20 (11) 8 (73) 11 (46)  < 0.001
Blood loss, mL, median (IQR) 100 (0–2400) 240 (50–1100) 425 (0–2100)  < 0.001
Operative time, minutes, median (IQR) 103 (20–513) 176 (61–347) 297 (60–513)  < 0.001
Any morbidity 47 (26) 5 (45) 14 (58) 0.109
Major morbidity 14 (8) 3 (13) 0.446
Reoperation rate 4 (2) 1 (4) 0.736
Biliary Leakage 5 (3) 1 (4) 0.788
Hemorrhage 2 (1) 1 (4) 0.458
Liver failure 1 (4) 0.02
Postoperative hospital stay, days, median (IQR) 3 (1–44) 5 (2–9) 6 (3–25)  < 0.001
90-day mortality 1 (9) 1 (4) 0.083

Bold values represent statistically significant p-values  (< 0.05)